Review article: ulcerative colitis, smoking and nicotine therapy

Abstract

SummaryBackgroundSmoking is the best‐characterised environmental association of ulcerative colitis (UC). Smoking has been observed to exert protective effects on both the development and progression of UC.AimsTo examine the association between UC and smoking, possible pathogenic mechanisms and the potential of nicotine as a therapeutic agent in the treatment of UC.MethodsA literature search was conducted through MEDLINE, using the MeSH search terms ‘ulcerative colitis’ and ‘smoking’ or ‘nicotine’. Relevant articles were identified through manual review. The reference lists of these articles were reviewed to include further appropriate articles.ResultsUlcerative colitis is less prevalent in smokers. Current smokers with a prior diagnosis of UC are more likely to exhibit milder disease than ex‐smokers and nonsmokers. There is conflicting evidence for smokers having reduced rates of hospitalisation, colectomy and need for oral corticosteroids and immunosuppressants to manage their disease. Multiple potential active mediators in smoke may be responsible for these clinical effects, including nicotine and carbon monoxide, but the precise mechanism remains unknown. Nicotine has demonstrated variable efficacy in the induction of remission in UC when compared to placebo and conventional medicines. Despite this, the high frequency of adverse events limits its clinical significance.ConclusionsNicotine's application as a therapeutic treatment in ulcerative colitis is limited. Presently, it may be an option considered only in selected cases of acute ulcerative colitis refractory to conventional treatment options. This review also questions whether nicotine is the active component of smoking that modifies risk and inflammation in ulcerative colitis.

Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia

“…[8] The relative contribution of these IBD environmental risk factors may differ according to the population studied. A comparison of these relative contributions between native-versus migrating-populations have never been assessed.…”

Colonic motility in ulcerative colitis

“…16,17 Since there is some evidence that UC is less prevalent in smokers, a possible role for nicotine as anti-inflammatory agent in this condition has been postulated. 18 Therefore, it is not surprising that investigations also appeared concerning the possible effects of nicotine on colonic motor activity in these subjects. A first study carried out (but only in the rectosigmoid area) in patients with UC in remission did not show significant differences between patients and controls with respect to motility and smooth muscle tone.…”

The Therapeutic Potential of Carbon Monoxide for Inflammatory Bowel Disease

“…In CD, smoking is positively correlated with the development of intestinal inflammation. Interestingly, some studies have established a higher rate of ileal complication and a lower prevalence of colonic complication in CD patients who are smokers [34]. These findings suggest that smoking may provide a protective effect to the large intestine.…”